tiprankstipranks
Advertisement
Advertisement
Viridian Therapeutics price target lowered to $36 from $40 at Truist
PremiumThe FlyViridian Therapeutics price target lowered to $36 from $40 at Truist
6d ago
Amgen price target raised to $325 from $319 at Truist
Premium
The Fly
Amgen price target raised to $325 from $319 at Truist
6d ago
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
Premium
The Fly
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
6d ago
Stifel sees path towards differentiation for Viridian after Amgen data
PremiumThe FlyStifel sees path towards differentiation for Viridian after Amgen data
7d ago
Amgen announces ‘positive’ results from Phase 3 trial of tepezza
Premium
The Fly
Amgen announces ‘positive’ results from Phase 3 trial of tepezza
7d ago
Evercore cuts Viridian price target, removes from ‘Tactical Outperform’ list
Premium
The Fly
Evercore cuts Viridian price target, removes from ‘Tactical Outperform’ list
12d ago
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe FlyAmgen price target raised to $390 from $375 at Wells Fargo
26d ago
Amgen initiated with a Hold at Jefferies
Premium
The Fly
Amgen initiated with a Hold at Jefferies
1M ago
Kyowa Kirin announces discontinuation of rocatinlimab clinical trials
Premium
The Fly
Kyowa Kirin announces discontinuation of rocatinlimab clinical trials
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100